Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
206 studies found for:    Bronchitis, Chronic
Show Display Options
Rank Status Study
21 Recruiting Effect of Losartan on Airway Mucociliary Dysfunction in Patients With COPD and Chronic Bronchitis
Conditions: COPD;   Chronic Bronchitis
Interventions: Drug: Losartan 50 mg;   Drug: losartan 100 mg
22 Completed Safety/Tolerability and Efficacy of YHD001 in Patients With Acute and Chronic Bronchitis
Conditions: Acute Bronchitis;   Chronic Bronchitis
Interventions: Drug: YHD001 dose level 1;   Drug: YHD001 dose level 2;   Drug: Pelargonium sidoides extract;   Drug: placebo
23 Completed Dietary and Genetic Factors in Asthma & Chronic Bronchitis in a Cohort of Chinese Singaporeans
Conditions: Chronic Bronchitis;   Asthma
Intervention:
24 Completed SYMPROVE III: Health Services Research Study for Treatment of the Moderate and Severe Acute Exacerbations of Chronic Bronchitis (AECB)
Condition: Chronic Bronchitis
Intervention: Drug: Moxifloxacin (Avelox, BAY12-8039)
25 Completed A Study of the Effectiveness and Safety of High Dose, Short-course Levofloxacin in the Treatment of Acute Bacterial Exacerbation (Worsening) of Chronic Bronchitis.
Conditions: Bronchitis;   Chronic Bronchitis
Intervention: Drug: levofloxacin, azithromycin, amoxicillin/clavulanate
26 Unknown  A Multi-center, Randomized, Double-blind, Double-dummy Clinical Study to Evaluate the Safety and Efficacy of Prulifloxacin Film-coated Tablet for the Treatment of Acute Exacerbations of Chronic Bronchitis With Levofloxacin Hydrochloride Tablet as Active Control
Condition: Acute Exacerbations of Chronic Bronchitis
Interventions: Drug: Prulifloxacin;   Drug: Levofloxacin;   Drug: Levofloxacin Placebo;   Drug: Prulifloxacin placebo
27 Completed Epidemiology of Chronic Bronchitis in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Chronic Obstructive Pulmonary Disease;   Chronic Bronchitis
Intervention:
28 Completed A Blinded Study Comparing the Safety and Efficacy of a Fully Human Anti-IL8 Monoclonal Antibody (ABX-IL8) to Placebo in Patients With Chronic Bronchitis and COPD
Conditions: Pulmonary Disease, Chronic Obstructive;   Bronchitis, Chronic
Intervention: Drug: ABX-IL8
29 Active, not recruiting Sustained Effects of Hypertonic Saline on Mucociliary Clearance in Subjects With Chronic Bronchitis
Conditions: Chronic Obstructive Pulmonary Disease;   COPD;   Chronic Bronchitis
Intervention: Other: Inhaled 7% HS (NaCl) home treatment
30 Completed Effect of BIBW 2948 BS in COPD
Conditions: Pulmonary Disease, Chronic Obstructive;   Bronchitis, Chronic
Interventions: Drug: BIBW 2948 BS;   Drug: Placebo
31 Completed A Multicenter, Randomized, Double-blind, Parallel Group Study to Determine the Optimal Dose of HL301 After 7 Days Oral Administration in Acute Bronchitis or Acute Exacerbations of Chronic Bronchitis Patients (HL301: Mixed Extract of Rehmannia Glutinosa, Schisandra and so on)
Conditions: Acute Bronchitis;   Acute Exacerbations of Chronic Bronchitis
Interventions: Drug: HL301 300mg capsule;   Drug: Placebo
32 Withdrawn Safety and Efficacy of 4-weeks Treatment of BIBW 2948 BS in Patients With Chronic Obstructive Bronchitis
Conditions: Pulmonary Disease, Chronic Obstructive;   Bronchitis, Chronic
Intervention: Drug: BIBW 2948 BS
33 Completed Phase 2 Study - Erdosteine in Patients With CB/COPD
Conditions: Chronic Bronchitis;   Chronic Obstructive Pulmonary Disease
Intervention: Drug: Erdosteine
34 Unknown  N-Acetylcysteine for Patients With COPD and ChronicBronchitis
Conditions: Chronic Obstructive Pulmonary Disease;   Chronic Bronchitis
Interventions: Drug: N-acetylcysteine;   Drug: Oral acetylcysteine
35 Completed Greatest International Antiinfective Trial With Avelox
Conditions: Bronchitis, Chronic;   Bronchial Diseases
Intervention: Drug: Moxifloxacin (Avelox, BAY12-8039)
36 Withdrawn Novel Therapies for Muco-Obstructive Lung Diseases: Testing the Transnasal Pulmonary Delivery Device in COPD/CB Subjects
Conditions: COPD;   Chronic Bronchitis
Interventions: Device: tPAD;   Device: 7% hypertonic saline (510K approved as a device)
37 Completed Ceftidoren Versus Levofloxacin in the Treatment of Patients With Acute Exacerbations of Chronic Bronchitis (AECB)
Condition: COPD Exacerbation
Interventions: Drug: ceftidoren;   Drug: levofloxacin
38 Completed Ketek in CAP / AECB in Ambulatory Adult Patients
Conditions: Community Acquired Pneumonia (CAP);   Acute Exacerbation of Chronic Bronchitis (AECB)
Intervention: Drug: Telithromycin
39 Completed Respiratory Therapy in COPD Exacerbations
Condition: Obstructive Chronic Bronchitis With Acute Exacerbation
Interventions: Other: No Respiratory Therapy;   Other: Respiratory Therapy
40 Completed Outcomes of Patients Not Responding to Antibiotics in the Community
Conditions: Sinusitis;   Bronchitis, Chronic;   Pneumonia, Bacterial
Interventions: Drug: all macrolide antibiotics;   Drug: all beta-lactam antibiotics

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.